Related Experiment Video

Updated: Jul 21, 2025

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.0K

Development of an orally bioavailable selective inhibitor of the menin-MLL

Hai-Jing Zhong1,2,3, Wanhe Wang4, Wei Zhou2

  • 1State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China.

Genes & Diseases
|July 26, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

401
Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

2.6K

Related Experiment Videos

Last Updated: Jul 21, 2025

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.0K
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

401
Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

2.6K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K

Articles linked to this work by shared authors, journal, and citation graph.

A Subcellular Keap1-Nrf2 Disruption Strategy for Atopic Dermatitis Therapy.

Journal of medicinal chemistry·2026

Unraveling MARCH6's role in cancer progression and metabolism from protein homeostasis to oncogenesis.

Pharmacological research·2026

Bioorthogonal Iridium(III) Complexes: A New Frontier of Luminescent Iridium(III) Complexes for Biomedical Applications.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026

Dual-Receptor Targeted Imaging of Cancer Cells with a Bioorthogonal Iridium(III)-Based Probe.

Inorganic chemistry·2026

Dissecting Mitochondrial Sulfur Dioxide Generation Mechanism in Rheumatoid Arthritis with a NIR Luminogenic Iridium(III)-Based Probe.

Analytical chemistry·2026

Imaging mitochondrial hydrogen sulfide in multicellular spheroids using a near-infrared iridium(III) complex.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026

Steatotic liver-derived extracellular vesicles deliver ACSL4 to potentiate hepatic ischemia-reperfusion injury by orchestrating a ferroptosis-mitochondrial apoptosis cascade.

Genes & diseases·2026

LAMA5 pathogenic variant uncovers a novel autoantigen in membranous nephropathy.

Genes & diseases·2026

PINK1 deficiency exacerbates age-related bone loss in association with enhanced inflammatory adipocyte differentiation.

Genes & diseases·2026

Single-cell sequencing-guided discovery of narciclasine as a dual VCAM-1/ICAM-1 inhibitor for atherosclerosis management.

Genes & diseases·2026

Autosomal dominant gain-of-function mutations in LCP1 cause a syndromic neutropenia and immunodeficiency.

Genes & diseases·2026

High-throughput chemical screen identifies epothilone B in modulating inflammatory bowel disease by triggering neutrophil apoptosis.

Genes & diseases·2026

Screening of a chemogenetic library unveils dual-stage antiplasmodials with low cytotoxicity.

Antimicrobial agents and chemotherapy·2026

LigGen: A Tool for Predicting Water Positions in Proteins.

Molecular informatics·2026

Using molecular modeling and QSAR-based design strategies for advancing the development of therapeutic solute carrier 6 (SLC6) transporter ligands.

Expert opinion on drug discovery·2026

Structure and mechanism of HDV ribozymes revealing Lewis acid catalysis by a metal ion.

Nature communications·2026

Conformer-covariance diagnostics for aqueous solubility.

Journal of computer-aided molecular design·2026

Mechanism-aware and safety-validated AI for drug repurposing: a critical review and translational pharmacology framework.

Frontiers in pharmacology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us